Literature DB >> 18845779

Differential distribution of muscle and skin sympathetic nerve activity in patients with end-stage renal disease.

Jeanie Park1, Vito M Campese, Niloofar Nobakht, Holly R Middlekauff.   

Abstract

End-stage renal disease (ESRD) is characterized by resting sympathetic overactivity. Baseline muscle sympathetic nerve activity (MSNA), which is governed by baroreflexes and chemoreflexes, is elevated in ESRD. Whether resting skin sympathetic nerve activity (SSNA), which is independent from baroreflex and chemoreflex control, is also elevated has never been reported in renal failure. The purpose of this study was to determine whether sympathetic overactivity of ESRD is generalized to include the skin distribution. We measured sympathetic nerve activity to both muscle and skin using microneurography in eight ESRD patients and eight controls. MSNA was significantly (P = 0.025) greater in ESRD (37.3 +/- 3.6 bursts/min) when compared with controls (23.1 +/- 4.4 bursts/min). However, SSNA was not elevated in ESRD (ESRD vs. controls, 17.6 +/- 2.2 vs. 16.1 +/- 1.7 bustst/min, P = 0.61). Similar results were obtained when MSNA was quantified as bursts per 100 heartbeats. We report the novel finding that although sympathetic activity directed to muscle is significantly elevated, activity directed to skin is not elevated in ESRD. The differential distribution of sympathetic outflow to the muscle vs. skin in ESRD is similar to the pattern seen in other disease states characterized by sympathetic overactivity such as heart failure and obesity.

Entities:  

Mesh:

Year:  2008        PMID: 18845779      PMCID: PMC2612470          DOI: 10.1152/japplphysiol.90849.2008

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  30 in total

1.  Microneurography: how the technique developed and its role in the investigation of the sympathetic nervous system.

Authors:  Ake B Vallbo; Karl-Erik Hagbarth; B Gunnar Wallin
Journal:  J Appl Physiol (1985)       Date:  2004-04

2.  Endothelial dysfunction and hypertension in 5/6 nephrectomized rats are mediated by vascular superoxide.

Authors:  Galit Hasdan; Sydney Benchetrit; Gloria Rashid; Janice Green; Jacques Bernheim; Mauro Rathaus
Journal:  Kidney Int       Date:  2002-02       Impact factor: 10.612

3.  Manoeuvres affecting sympathetic outflow in human skin nerves.

Authors:  W Delius; K E Hagbarth; A Hongell; B G Wallin
Journal:  Acta Physiol Scand       Date:  1972-02

4.  General characteristics of sympathetic activity in human skin nerves.

Authors:  K E Hagbarth; R G Hallin; A Hongell; H E Torebjörk; B G Wallin
Journal:  Acta Physiol Scand       Date:  1972-02

5.  General characteristics of sympathetic activity in human muscle nerves.

Authors:  W Delius; K E Hagbarth; A Hongell; B G Wallin
Journal:  Acta Physiol Scand       Date:  1972-01

6.  Moxonidine normalizes sympathetic hyperactivity in patients with eprosartan-treated chronic renal failure.

Authors:  Jutta Neumann; Gerry Ligtenberg; Liam Oey; Hein A Koomans; Peter J Blankestijn
Journal:  J Am Soc Nephrol       Date:  2004-11       Impact factor: 10.121

7.  Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension.

Authors:  Inge H H T Klein; Gerry Ligtenberg; P Liam Oey; Hein A Koomans; Peter J Blankestijn
Journal:  J Am Soc Nephrol       Date:  2001-11       Impact factor: 10.121

8.  Enalapril and losartan reduce sympathetic hyperactivity in patients with chronic renal failure.

Authors:  Inge H H T Klein; Gerry Ligtenberg; P Liam Oey; Hein A Koomans; Peter J Blankestijn
Journal:  J Am Soc Nephrol       Date:  2003-02       Impact factor: 10.121

9.  Sympathetic nerve activity is inappropriately increased in chronic renal disease.

Authors:  Inge H H T Klein; Gerry Ligtenberg; Jutta Neumann; P Liam Oey; Hein A Koomans; Peter J Blankestijn
Journal:  J Am Soc Nephrol       Date:  2003-12       Impact factor: 10.121

10.  Analysis of the relationship between norepinephrine and asymmetric dimethyl arginine levels among patients with end-stage renal disease.

Authors:  Francesca Mallamaci; Giovanni Tripepi; Renke Maas; Lorenzo Malatino; Rainer Böger; Carmine Zoccali
Journal:  J Am Soc Nephrol       Date:  2004-02       Impact factor: 10.121

View more
  28 in total

Review 1.  Major Autonomic Neuroregulatory Pathways Underlying Short- and Long-Term Control of Cardiovascular Function.

Authors:  Ibrahim M Salman
Journal:  Curr Hypertens Rep       Date:  2016-03       Impact factor: 5.369

2.  Human sympathetic outflows to skin and muscle target organs fluctuate concordantly over a wide range of time-varying frequencies.

Authors:  Alan Bernjak; Jian Cui; Satoshi Iwase; Tadaaki Mano; Aneta Stefanovska; Dwain L Eckberg
Journal:  J Physiol       Date:  2011-11-07       Impact factor: 5.182

3.  Sympathetic nerve traffic and asymmetric dimethylarginine in chronic kidney disease.

Authors:  Guido Grassi; Gino Seravalle; Lorenzo Ghiadoni; Giovanni Tripepi; Rosa Maria Bruno; Giuseppe Mancia; Carmine Zoccali
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-22       Impact factor: 8.237

4.  Cerebral blood flow regulation in end-stage kidney disease.

Authors:  Justin D Sprick; Joe R Nocera; Ihab Hajjar; W Charles O'Neill; James Bailey; Jeanie Park
Journal:  Am J Physiol Renal Physiol       Date:  2020-09-28

5.  Endothelial dysfunction correlates with exaggerated exercise pressor response during whole body maximal exercise in chronic kidney disease.

Authors:  Ryan M Downey; Peizhou Liao; Erin C Millson; Arshed A Quyyumi; Salman Sher; Jeanie Park
Journal:  Am J Physiol Renal Physiol       Date:  2017-03-08

Review 6.  Measuring and quantifying skin sympathetic nervous system activity in humans.

Authors:  Jody L Greaney; W Larry Kenney
Journal:  J Neurophysiol       Date:  2017-07-12       Impact factor: 2.714

Review 7.  Nutraceuticals as a potential adjunct therapy toward improving vascular health in CKD.

Authors:  Nicholas T Kruse
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-10-02       Impact factor: 3.619

Review 8.  Abnormal neurocirculatory control during exercise in humans with chronic renal failure.

Authors:  Jeanie Park; Holly R Middlekauff
Journal:  Auton Neurosci       Date:  2014-10-22       Impact factor: 3.145

Review 9.  Role of the sympathetic nervous system in hypertension and hypertension-related cardiovascular disease.

Authors:  Gino Seravalle; Giuseppe Mancia; Guido Grassi
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-05-01

Review 10.  Cardiovascular Autonomic Dysfunction in Chronic Kidney Disease: a Comprehensive Review.

Authors:  Ibrahim M Salman
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.